SABS
SAB Biotherapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:33:46 PM EST
2.91USD-8.906%(-0.29)1,232,440
Loading…
Loading…
259.01M
Healthcare
Biotechnology
HQ
Sioux Falls, SD, USA
Previous Close
$3.20
Beta
1.07
52-Week High
$5.15 2026-03-12
52-Week Low
$2.44 2026-10-19
SMA 50
$3.09
SMA 200
$3.61
Avg. Vol 10D
729,792
Avg. Vol 30D
689,332
Avg. Vol 90D
561,740
Relative Vol
1.92
90.09M
80.72M
89.60%
5,026,127
6.16%
8.28
49%/51%
80.08%
57.14%
4.9000%
3,600,000
115
115
Jan 5, 2024 · 1-for-10 (reverse)
-80.5M
-58.8M
-42.83
Nov 17, 2026
SAB Biotherapeutics at UBS conference: late-stage diabetes bet ·
Investing.com
Nov 6, 2026
SAB Biotherapeutics (SABS) Q3 2026 Earnings Call Transcript ·
The Motley Fool
SABS Profile
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.
SABS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.08 | 2026-11-12 | -6.66% | 1.051 |
| 1M | 2.60 | 2026-10-19 | +10.58% | 1.062 |
| 3M | 3.78 | 2026-08-19 | -23.94% | 1.115 |
| 6M | 3.55 | 2026-05-19 | -19.01% | 1.410 |
| 1Y | 3.83 | 2025-11-19 | -24.93% | 1.068 |
| 2Y | 3.24 | 2024-11-19 | -11.27% | — |
| 5Y | 110.30 | 2021-11-19 | -97.39% | 0.785 |
SABS Stock Summary
SAB Biotherapeutics, Inc. Common Stock (NASDAQ:SABS) stock price today is $2.88, and today's volume is 1,320,109. SABS is down 10.156% today. The 30 day average volume is 689,332. SABS market cap is $259.01M with 90.09M shares outstanding.